Timothy Voorhees

Timothy Voorhees is a clinical researcher focused on lymphoma and related blood cancers, with particular attention to CAR-T cell therapy (a treatment that engineers a patient's own immune cells to attack cancer), bispecific antibodies, and other novel immunotherapies. Much of the work involves multicenter clinical trials and real-world outcome studies examining safety, effectiveness, and toxicity of these treatments in patients with relapsed or hard-to-treat lymphomas. The research is highly clinical and collaborative, drawing on data from many academic medical centers across the United States.

Publication output has grown substantially over the past decade, rising from a handful of papers around 2018-2019 to over 20 per year since 2022, indicating an active and expanding research program.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026